FENC Competitors & Alternatives
Compare Fennec Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
FENC
Main Stock$10.08
Tradestie Score
48
Market Cap
$266.91M
Revenue Growth
0.9%
Analyst Upside
+75.3%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.80
|
$407.71M | - | 53 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.24
|
$386.68M | - | 53 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.30
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.16
|
$371.64M | - | 61 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$8.72
|
$354.59M | - | 46 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.37
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$38.73
|
$353.70M | 394.2 | 48 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.41
|
$350.98M | - | 68 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.75
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.46
|
$328.62M | - | 49 | Compare |
More FENC Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry